Top Featuring Companies Dominating the Global Opioid Dependence Treatment Market
- Orexo AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT AnalysisÂ
- Indivior PLC
- Titan Pharmaceuticals, Inc.
- Viatris Inc.
- Pfizer, Inc.
- Hikma Pharmaceuticals PLC
- BioDelivery Sciences International Inc.
- Teva Pharmaceutical Industries Ltd.
- Alkermes
- Camurus AB
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Opioid Dependence Treatment Market in 2025 is assessed at USD 3.89 billion.
The global market size surpassed USD 3.61 billion in 2024 and is projected to witness a CAGR of over 9.7%, crossing USD 12.03 billion revenue by 2037.
Asia Pacific is poised to generate USD 4.69 billion by 2037, fueled by increasing awareness about opioid use disorder and the large patient pool in the region.
The major players in the market include Orexo AB, Indivior PLC, Titan Pharmaceuticals, Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, BioDelivery Sciences International Inc., Teva Pharmaceutical Industries Ltd., Alkermes, Camurus AB.
